United Therapeutics

Premium Company Profile

Publication Date	December 2007
Publisher	Datamonitor
Product Type	Report
Pages	50
ISBN Number	not applicable
Product Code	DAT09088

Price

£265.00
approximately: $387 | €290

PDF

PRINT £315 ($460 | €345)

Order above formats by FAX

Summary

Introduction

United Therapeutics was originally created as a biotechnology company focused on the development and commercialization of products for patients with chronic and life threatening cardiovascular, cancer and infectious diseases. In 2000, the company entered the telemedicine products and services market through a series of acquisitions which included Cooke Pharma, Medicomp and Telemedical Procedures.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

United Therapeutics' research and development efforts are focused primarily on Identification and development of Prostacyclin Analogs, Glycobiology Antiviral Agents and Immunotherapeutic Monoclonal Antibodies

The company's total revenues increased at a CAGR of 52% during 2002-2006, from $30 million to $160 million. This represents an absolute total growth of +$130 million for total revenues. The company's biggest contributor to revenue growth during 2002-2006 was product sales Remodulin

The company's biggest contributor to sales growth out to 2010 will be product sales of Inhaled Remodulin. Revenues from Inhaled Remodulin are expected to reach $146 million in 2010. This represents an absolute growth of +$146 million, which is 39% of United Therapeutics' total forecast growth

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Overview
Catalyst
Summary
- Company Structure
- Company Overview And Key Facts
- Business Description
- History
- Locations And Subsidiaries
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Products & Services
- Marketed Products
- Pipeline Products
- Historical Product Sales
- Ac Forecast Product Sales
- Competitors And Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- Swot Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Discovery And Product Development
- Manufacturing
- Sales
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List Of Key Employees
- Key Employee Biographies
- Financial And Operational Overview
- Financial And Operational Overview
Appendix
Ask The Analyst
Datamonitor Consulting
Disclaimerr
Table Of Figures
- Figure 1: United Therapeutics - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: United Therapeutics - Key Strategic Revenues, 2002-2006 ($ Mn)
- Figure 3: United Therapeutics - Key Strategic Revenues, 2006-2010 ($ Mn)
Table Of Tables
- Table 1: United Therapeutics - Key Facts
- Table 2: United Therapeutics - Locations And Subsidiaries
- Table 3: United Therapeutics - Year-End Share Price And Market Capitalization, 2002-2006 ($)
- Table 4: United Therapeutics - Key Events Impacting Share Price Performance
- Table 5: United Therapeutics - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 6: United Therapeutics - Operating Cost Ratio Analysis, 2002-2006 (% Of Total Revenues)
- Table 7: United Therapeutics - Balance Sheet, 2002-2006 ($ Mn)
- Table 8: United Therapeutics - Cash Flow, 2002-2006 ($ Mn)
- Table 9: United Therapeutics - Revenue Breakdown By Division, 2002-2006 ($ Mn)
- Table 10: United Therapeutics - Marketed Products
- Table 11: United Therapeutics - In-House Pipeline Products
- Table 12: United Therapeutics - Collaboration Products
- Table 13: United Therapeutics - Historical Product Sales, 2002-2006 ($ Mn)
- Table 14: United Therapeutics - Forecast Sales, 2006-2010 ($ Mn)
- Table 15: United Therapeutics - Key Competitors
- Table 16: United Therapeutics - Key Suppliers
- Table 17: United Therapeutics - Key Clients
- Table 18: United Therapeutics - Key Shareholders
- Table 19: United Therapeutics - Swot Analysis Summary
- Table 20: United Therapeutics - Value Chain Analysis
- Table 21: United Therapeutics - Scorecard
- Table 22: United Therapeutics - Key Employees
- Table 23: United Therapeutics - Financial And Operational Overview